Balyasny Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Buy
391,149
+352,372
+909% +$2.45M ﹤0.01% 1687
2025
Q4
$273K Buy
+38,777
New +$234K ﹤0.01% 2763
2025
Q3
Sell
-63,727
Closed -$329K 3216
2025
Q2
$329K Buy
63,727
+46,740
+275% +$280K ﹤0.01% 2449
2025
Q1
$113K Buy
+16,987
New +$129K ﹤0.01% 2673
2023
Q2
Sell
-11,362
Closed -$84.4K 2558
2023
Q1
$84.4K Buy
+11,362
New +$63K ﹤0.01% 2335
2021
Q3
Sell
-125,000
Closed -$3.48M 2204
2021
Q2
$3.48M Buy
+125,000
New +$3.3M 0.02% 829

Other funds holding LFST

Balyasny Asset Management's LFST Position: Q1 2026 in Review

Balyasny Asset Management increased its Lifestance Health (LFST) stake by 909% in Q1 2026, buying an estimated $2.45M and bringing the position to 391,149 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Balyasny Asset Management first reported a position in LFST in Q2 2021 and has held it in 6 quarters since. The position peaked at $3.48M in Q2 2021. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Balyasny Asset Management held 391,149 shares of Lifestance Health worth $2.49M as of Q1 2026.
  • Balyasny Asset Management bought 352,372 Lifestance Health shares in Q1 2026, an estimated $2.45M.
  • Lifestance Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1687 holding.
  • Balyasny Asset Management first reported a position in Lifestance Health in Q2 2021 and has held it in 6 quarters since.
  • Balyasny Asset Management's Lifestance Health position peaked at $3.48M in Q2 2021.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.